{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:03:55Z","timestamp":1791745435656,"version":"4.3.4"},"reference-count":196,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00203-026-04817-6","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:48:17Z","timestamp":1773758897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Beyond new pills: integrative strategies to overcome multidrug-resistant bacteria"],"prefix":"10.1007","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4398-003X","authenticated-orcid":false,"given":"Poonam","family":"Sahu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trilochan","family":"Satapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"4817_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/v11020096","volume":"11","author":"K Abdelkader","year":"2019","unstructured":"Abdelkader K, Gerstmans H, Saafan A et al (2019) The preclinical and clinical progress of bacteriophages and their lytic enzymes: the parts are easier than the whole. Viruses 11:96. https:\/\/doi.org\/10.3390\/v11020096","journal-title":"Viruses"},{"key":"4817_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57060522","volume":"57","author":"H Adikesavalu","year":"2021","unstructured":"Adikesavalu H, Gopalaswamy R, Kumar A et al (2021) Autophagy induction as a host-directed therapeutic strategy against Mycobacterium tuberculosis infection. Medicina (b Aires) 57:522. https:\/\/doi.org\/10.3390\/medicina57060522","journal-title":"Medicina (b Aires)"},{"key":"4817_CR3","doi-asserted-by":"crossref","unstructured":"Ahmad SI (2021) Phage therapy of human bacterial infections: a systematic review. In: Human viruses: diseases, treatments and vaccines. Springer International Publishing, Cham, pp. 663\u2013692","DOI":"10.1007\/978-3-030-71165-8_32"},{"key":"4817_CR4","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.apt.2018.03.025","volume":"29","author":"B Ahmed","year":"2018","unstructured":"Ahmed B, Hashmi A, Khan MS, Musarrat J (2018) ROS mediated destruction of cell membrane, growth and biofilms of human bacterial pathogens by stable metallic AgNPs functionalized from bell pepper extract and quercetin. Adv Powder Technol 29:1601\u20131616. https:\/\/doi.org\/10.1016\/j.apt.2018.03.025","journal-title":"Adv Powder Technol"},{"key":"4817_CR5","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.2147\/IDR.S494327","volume":"17","author":"M Ahmed","year":"2024","unstructured":"Ahmed M, Kayode H, Okesanya O et al (2024) CRISPR-Cas systems in the fight against antimicrobial resistance: current status, potentials, and future directions. Infect Drug Resist 17:5229\u20135245. https:\/\/doi.org\/10.2147\/IDR.S494327","journal-title":"Infect Drug Resist"},{"key":"4817_CR6","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1109\/JBHI.2017.2778263","volume":"22","author":"A Al Kawam","year":"2018","unstructured":"Al Kawam A, Sen A, Datta A, Dickey N (2018) Understanding the bioinformatics challenges of integrating genomics into healthcare. IEEE J Biomed Health Inform 22:1672\u20131683. https:\/\/doi.org\/10.1109\/JBHI.2017.2778263","journal-title":"IEEE J Biomed Health Inform"},{"key":"4817_CR7","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/ph15101283","volume":"15","author":"O Al Musaimi","year":"2022","unstructured":"Al Musaimi O, Lombardi L, Williams DR, Albericio F (2022) Strategies for improving peptide stability and delivery. Pharmaceuticals 15:1283. https:\/\/doi.org\/10.3390\/ph15101283","journal-title":"Pharmaceuticals"},{"key":"4817_CR8","doi-asserted-by":"publisher","unstructured":"Albaqawi AF, Alduaiji SF, Alduaiji RF, et al (2025) The synergistic role of interprofessional healthcare teams in advancing antimicrobial stewardship programs. Saudi J Med Pharm Sci 11:581\u2013593. https:\/\/doi.org\/10.36348\/sjmps.2025.v11i07.014","DOI":"10.36348\/sjmps.2025.v11i07.014"},{"key":"4817_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5530\/phrev.20252224","volume":"19","author":"AF Albukhari","year":"2025","unstructured":"Albukhari AF (2025) AI-guided phytochemical and drug synergy mapping of Peganum harmala and Nigella sativa in cancer therapy. Pharmacogn Rev 19:48\u201360. https:\/\/doi.org\/10.5530\/phrev.20252224","journal-title":"Pharmacogn Rev"},{"key":"4817_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biology11091328","volume":"11","author":"R Alenazy","year":"2022","unstructured":"Alenazy R (2022) Drug efflux pump inhibitors: a promising approach to counter multidrug resistance in Gram-Negative pathogens by targeting AcrB protein from AcrAB-TolC multidrug efflux pump from Escherichia coli. Biology (Basel) 11:1328. https:\/\/doi.org\/10.3390\/biology11091328","journal-title":"Biology (Basel)"},{"key":"4817_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-023-00742-2","volume":"29","author":"NH Ali","year":"2023","unstructured":"Ali NH, Al-kuraishy HM, Al-Gareeb AI et al (2023) Autophagy and autophagy signaling in Epilepsy: possible role of autophagy activator. Mol Med 29:142. https:\/\/doi.org\/10.1186\/s10020-023-00742-2","journal-title":"Mol Med"},{"key":"4817_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17111426","volume":"17","author":"OM Alidriss","year":"2025","unstructured":"Alidriss OM, AlSudais H, Alhumaidan OS et al (2025) Targeted drug delivery strategies in overcoming antimicrobial resistance: advances and future directions. Pharmaceutics 17:1426. https:\/\/doi.org\/10.3390\/pharmaceutics17111426","journal-title":"Pharmaceutics"},{"key":"4817_CR13","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.2147\/IJN.S453566","volume":"19","author":"K Allemailem","year":"2024","unstructured":"Allemailem K (2024) Recent advances in understanding the molecular mechanisms of multidrug resistance and novel approaches of CRISPR\/Cas9-based genome-editing to combat this health emergency. Int J Nanomedicine 19:1125\u20131143. https:\/\/doi.org\/10.2147\/IJN.S453566","journal-title":"Int J Nanomedicine"},{"key":"4817_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/systems13030157","volume":"13","author":"B Almadani","year":"2025","unstructured":"Almadani B, Kaisar H, Thoker IR, Aliyu F (2025) A systematic survey of distributed decision support systems in healthcare. Systems (Basel) 13:157. https:\/\/doi.org\/10.3390\/systems13030157","journal-title":"Systems (Basel)"},{"key":"4817_CR15","doi-asserted-by":"publisher","unstructured":"Al-Ouqaili MTS, Ahmad A, Jwair NA, Al-Marzooq F (2025) Harnessing bacterial immunity: CRISPR-Cas system as a versatile tool in combating pathogens and revolutionizing medicine. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2025.1588446","DOI":"10.3389\/fcimb.2025.1588446"},{"key":"4817_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00350-23","author":"TA Alsenani","year":"2023","unstructured":"Alsenani TA, Viviani SL, Papp-Wallace KM et al (2023) Exploring avibactam and relebactam inhibition of Klebsiella pneumoniaecarbapenemase D179N variant: role of the \u03a9 loop-held deacylation water. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/aac.00350-23","journal-title":"Antimicrob Agents Chemother"},{"key":"4817_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/polym14061221","volume":"14","author":"M Alshamrani","year":"2022","unstructured":"Alshamrani M (2022) Broad-spectrum theranostics and biomedical application of functionalized nanomaterials. Polymers Basel 14:1221. https:\/\/doi.org\/10.3390\/polym14061221","journal-title":"Polymers Basel"},{"key":"4817_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28207008","volume":"28","author":"SS Ambade","year":"2023","unstructured":"Ambade SS, Gupta VK, Bhole RP et al (2023) A review on five and six-membered heterocyclic compounds targeting the penicillin-binding protein 2 (PBP2A) of methicillin-resistant Staphylococcus aureus (MRSA). Molecules Basel 28:7008. https:\/\/doi.org\/10.3390\/molecules28207008","journal-title":"Molecules Basel"},{"key":"4817_CR19","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s12602-025-10573-8","volume":"17","author":"RA Amen","year":"2025","unstructured":"Amen RA, Hassan YM, Essmat RA et al (2025) Harnessing the microbiome: CRISPR-based gene editing and antimicrobial peptides in combating antibiotic resistance and cancer. Probiotics Antimicrob Proteins 17:1938\u20131968. https:\/\/doi.org\/10.1007\/s12602-025-10573-8","journal-title":"Probiotics Antimicrob Proteins"},{"key":"4817_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2025.101847","volume":"91","author":"C Antoine","year":"2025","unstructured":"Antoine C, Mackay D, Midtlyng P et al (2025) Bacteriophage-based veterinary products: aligning regulatory framework and development challenges for market integration. Biologicals 91:101847. https:\/\/doi.org\/10.1016\/j.biologicals.2025.101847","journal-title":"Biologicals"},{"key":"4817_CR21","doi-asserted-by":"publisher","unstructured":"Augustyniak D, Majkowska-Skrobek G, Roszkowiak J, Dorotkiewicz-Jach A (2017) Defensive and offensive cross-reactive antibodies elicited by pathogens: the good, the bad and the ugly. Curr Med Chem. https:\/\/doi.org\/10.2174\/0929867324666170508110222","DOI":"10.2174\/0929867324666170508110222"},{"key":"4817_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.105863","volume":"55","author":"LM Avery","year":"2020","unstructured":"Avery LM, Mullane EM, Nicolau DP (2020) Evaluation of the in vitro activity of WCK 5222 (cefepime\/zidebactam) and currently available combination therapies against single- and double-carbapenemase producing Enterobacteriaceae: expanding the zone of hope. Int J Antimicrob Agents 55:105863. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.105863","journal-title":"Int J Antimicrob Agents"},{"key":"4817_CR23","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01658-17","author":"NE Babady","year":"2018","unstructured":"Babady NE, England MR, Jurcic Smith KL et al (2018) Multicenter evaluation of the ePlex respiratory pathogen panel for the detection of viral and bacterial respiratory tract pathogens in nasopharyngeal swabs. J Clin Microbiol. https:\/\/doi.org\/10.1128\/JCM.01658-17","journal-title":"J Clin Microbiol"},{"key":"4817_CR24","doi-asserted-by":"publisher","unstructured":"Barrett JS, Oskoui SE, Russell S, Borens A (2023) Digital research environment (DRE)-enabled artificial intelligence (AI) to facilitate early stage drug development. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1115356","DOI":"10.3389\/fphar.2023.1115356"},{"key":"4817_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/chemengineering9030056","volume":"9","author":"S Basak","year":"2025","unstructured":"Basak S, Das TK (2025) Liposome-based drug delivery systems: from laboratory research to industrial production\u2014instruments and challenges. ChemEngineering 9:56. https:\/\/doi.org\/10.3390\/chemengineering9030056","journal-title":"ChemEngineering"},{"key":"4817_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s44222-025-00311-8","volume":"3","author":"F Benz","year":"2025","unstructured":"Benz F, Beamud B, Laurenceau R et al (2025) CRISPR\u2013Cas therapies targeting bacteria. Nat Rev Bioeng 3:627\u2013644. https:\/\/doi.org\/10.1038\/s44222-025-00311-8","journal-title":"Nat Rev Bioeng"},{"key":"4817_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s12668-024-01654-z","volume":"15","author":"S Bharti","year":"2025","unstructured":"Bharti S, Kumar A (2025) Nanotechnology in targeted delivery of antimicrobials and overcoming resistance. Bionanoscience 15:20. https:\/\/doi.org\/10.1007\/s12668-024-01654-z","journal-title":"Bionanoscience"},{"key":"4817_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10096-021-04341-z","volume":"41","author":"G Bianco","year":"2022","unstructured":"Bianco G, Boattini M, Comini S et al (2022) In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effects. Eur J Clin Microbiol Infect Dis 41:63\u201370. https:\/\/doi.org\/10.1007\/s10096-021-04341-z","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4817_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13092194","volume":"13","author":"V Birlutiu","year":"2025","unstructured":"Birlutiu V, Birlutiu R-M (2025) An overview of the epidemiology of multidrug resistance and bacterial resistance mechanisms: what solutions are available? A comprehensive review. Microorganisms 13:2194. https:\/\/doi.org\/10.3390\/microorganisms13092194","journal-title":"Microorganisms"},{"key":"4817_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107150","volume":"63","author":"T Blanco-Mart\u00edn","year":"2024","unstructured":"Blanco-Mart\u00edn T, Alonso-Garc\u00eda I, Gonz\u00e1lez-Pinto L et al (2024) Activity of Cefiderocol and innovative \u03b2-lactam\/\u03b2-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double \u03b2-lactamases under high and low permeability conditions. Int J Antimicrob Agents 63:107150. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107150","journal-title":"Int J Antimicrob Agents"},{"key":"4817_CR31","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/v17091180","volume":"17","author":"A Bo\u0142oz","year":"2025","unstructured":"Bo\u0142oz A, Lannoy V, Olszak T et al (2025) Interplay between bacterial extracellular vesicles and phages: receptors, mechanisms, and implications. Viruses 17:1180. https:\/\/doi.org\/10.3390\/v17091180","journal-title":"Viruses"},{"key":"4817_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00397-20","author":"SE Boyd","year":"2020","unstructured":"Boyd SE, Livermore DM, Hooper DC, Hope WW (2020) Metallo-\u03b2-Lactamases: Structure, function, epidemiology, treatment options, and the development pipeline. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00397-20","journal-title":"Antimicrob Agents Chemother"},{"key":"4817_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12859-021-04161-0","volume":"22","author":"A Bruno","year":"2021","unstructured":"Bruno A, Aury J-M, Engelen S (2021) BoardION: real-time monitoring of Oxford nanopore sequencing instruments. BMC Bioinform 22:245. https:\/\/doi.org\/10.1186\/s12859-021-04161-0","journal-title":"BMC Bioinform"},{"key":"4817_CR34","doi-asserted-by":"publisher","unstructured":"Butler MS, Gigante V, Sati H, et al (2022) Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections: despite progress, more action is needed. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/aac.01991-21","DOI":"10.1128\/aac.01991-21"},{"key":"4817_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215756","volume":"14","author":"JL Cantera","year":"2019","unstructured":"Cantera JL, White H, Diaz MH et al (2019) Assessment of eight nucleic acid amplification technologies for potential use to detect infectious agents in low-resource settings. PLoS ONE 14:e0215756. https:\/\/doi.org\/10.1371\/journal.pone.0215756","journal-title":"PLoS ONE"},{"key":"4817_CR36","doi-asserted-by":"crossref","unstructured":"Chauhan P, Sarkar A, Saha B (2018) Interplay between metabolic sensors and immune cell signaling, pp. 115\u2013196","DOI":"10.1007\/978-3-319-74932-7_3"},{"key":"4817_CR37","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00353-25","author":"D Choe","year":"2025","unstructured":"Choe D, Lee E, Song Y et al (2025) CRISPRi screening reveals E. coli\u2019s anaerobic-like respiratory adaptations to gentamicin: Membrane depolarization by CpxR. mSystems. https:\/\/doi.org\/10.1128\/msystems.00353-25","journal-title":"mSystems"},{"key":"4817_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10121497","volume":"10","author":"KM Danis-Wlodarczyk","year":"2021","unstructured":"Danis-Wlodarczyk KM, Wozniak DJ, Abedon ST (2021) Treating bacterial infections with bacteriophage-based enzybiotics: in vitro, in vivo and clinical application. Antibiotics (Basel) 10:1497. https:\/\/doi.org\/10.3390\/antibiotics10121497","journal-title":"Antibiotics (Basel)"},{"key":"4817_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13071501","volume":"13","author":"J de Souza","year":"2025","unstructured":"de Souza J, D\u2019Espindula HRS, Ribeiro IdeF et al (2025) Carbapenem resistance in Acinetobacter baumannii: Mechanisms, therapeutics, and innovations. Microorganisms 13:1501. https:\/\/doi.org\/10.3390\/microorganisms13071501","journal-title":"Microorganisms"},{"key":"4817_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baad088","author":"CH Deng","year":"2023","unstructured":"Deng CH, Naithani S, Kumari S et al (2023) Genotype and phenotype data standardization, utilization and integration in the big data era for agricultural sciences. Database Oxf. https:\/\/doi.org\/10.1093\/database\/baad088","journal-title":"Database Oxf"},{"key":"4817_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/v16030478","volume":"16","author":"LMT Dicks","year":"2024","unstructured":"Dicks LMT, Vermeulen W (2024) Bacteriophage\u2013host interactions and the therapeutic potential of bacteriophages. Viruses (Basel) 16:478. https:\/\/doi.org\/10.3390\/v16030478","journal-title":"Viruses (Basel)"},{"key":"4817_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202510900","author":"Q Ding","year":"2025","unstructured":"Ding Q, Xie Y, Xiong K et al (2025) From light to cure: precision phototherapies for antibiotic\u2010refractory biofilm infections. Angew Chem Int Ed Engl. https:\/\/doi.org\/10.1002\/anie.202510900","journal-title":"Angew Chem Int Ed Engl"},{"key":"4817_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202402926","author":"C Dini","year":"2025","unstructured":"Dini C, Borges MHR, Malheiros SS et al (2025) Progress in designing therapeutic antimicrobial hydrogels targeting implant\u2010associated infections: paving the way for a sustainable platform applied to biomedical devices. Adv Healthc Mater. https:\/\/doi.org\/10.1002\/adhm.202402926","journal-title":"Adv Healthc Mater"},{"key":"4817_CR44","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/pat.5661","volume":"33","author":"G Divyashri","year":"2022","unstructured":"Divyashri G, Badhe RV, Sadanandan B et al (2022) Applications of < scp>hydrogel-based<\/scp> delivery systems in wound care and treatment: an up-to-date review. Polym Adv Technol 33:2025\u20132043. https:\/\/doi.org\/10.1002\/pat.5661","journal-title":"Polym Adv Technol"},{"key":"4817_CR45","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1134\/S0006297920110024","volume":"85","author":"AM Egorov","year":"2020","unstructured":"Egorov AM, Ulyashova MM, Rubtsova MYu (2020) Inhibitors of \u03b2-lactamases. New life of \u03b2-lactam antibiotics. Biochem Mosc 85:1292\u20131309. https:\/\/doi.org\/10.1134\/S0006297920110024","journal-title":"Biochem Mosc"},{"key":"4817_CR46","doi-asserted-by":"publisher","unstructured":"Ehsan H (2025) Antibiotic resistance in developing countries: emerging threats and policy responses. Public Health Challenges. https:\/\/doi.org\/10.1002\/puh2.70034","DOI":"10.1002\/puh2.70034"},{"key":"4817_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13071473","volume":"13","author":"A Elbehiry","year":"2025","unstructured":"Elbehiry A, Abalkhail A (2025) Spectral precision: recent advances in matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry for pathogen detection and resistance profiling. Microorganisms 13:1473. https:\/\/doi.org\/10.3390\/microorganisms13071473","journal-title":"Microorganisms"},{"key":"4817_CR48","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/pharmaceutics12020142","volume":"12","author":"NE Eleraky","year":"2020","unstructured":"Eleraky NE, Allam A, Hassan SB, Omar MM (2020) Nanomedicine fight against antibacterial resistance: an overview of the recent pharmaceutical innovations. Pharmaceutics 12:142. https:\/\/doi.org\/10.3390\/pharmaceutics12020142","journal-title":"Pharmaceutics"},{"key":"4817_CR49","doi-asserted-by":"publisher","first-page":"24450","DOI":"10.1039\/D5RA04047G","volume":"15","author":"H Elkady","year":"2025","unstructured":"Elkady H, Salman IN, Khalifa MM (2025) Small-molecule strategies to combat antibiotic resistance: mechanisms, modifications, and contemporary approaches. RSC Adv 15:24450\u201324474. https:\/\/doi.org\/10.1039\/D5RA04047G","journal-title":"RSC Adv"},{"key":"4817_CR50","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1080\/00325481.2021.1982297","volume":"133","author":"OL Elvir-Lazo","year":"2021","unstructured":"Elvir-Lazo OL, White PF, Cruz Eng H et al (2021) Impact of chronic medications in the perioperative period: mechanisms of action and adverse drug effects (Part I). Postgrad Med 133:939\u2013952. https:\/\/doi.org\/10.1080\/00325481.2021.1982297","journal-title":"Postgrad Med"},{"key":"4817_CR51","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1039\/D3MA00817G","volume":"5","author":"SC Emencheta","year":"2024","unstructured":"Emencheta SC, Onugwu AL, Kalu CF et al (2024) Bacteriophages as nanocarriers for targeted drug delivery and enhanced therapeutic effects. Mater Adv 5:986\u20131016. https:\/\/doi.org\/10.1039\/D3MA00817G","journal-title":"Mater Adv"},{"key":"4817_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1138596","author":"R Ewaisha","year":"2023","unstructured":"Ewaisha R, Anderson KS (2023) Immunogenicity of CRISPR therapeutics\u2014critical considerations for clinical translation. Front Bioeng Biotechnol. https:\/\/doi.org\/10.3389\/fbioe.2023.1138596","journal-title":"Front Bioeng Biotechnol"},{"key":"4817_CR53","doi-asserted-by":"crossref","unstructured":"Fatima Z, Purkait D, Rehman S, et al (2023) Multidrug resistance: a threat to antibiotic era. In: Biological and Environmental Hazards, Risks, and Disasters. Elsevier, pp. 197\u2013220","DOI":"10.1016\/B978-0-12-820509-9.00014-9"},{"key":"4817_CR54","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2171248","author":"ML Fern\u00e1ndez-Quintero","year":"2023","unstructured":"Fern\u00e1ndez-Quintero ML, Ljungars A, Waibl F et al (2023) Assessing developability early in the discovery process for novel biologics. Mabs. https:\/\/doi.org\/10.1080\/19420862.2023.2171248","journal-title":"Mabs"},{"key":"4817_CR55","doi-asserted-by":"publisher","unstructured":"Fleitas Mart\u00ednez O, Cardoso MH, Ribeiro SM, Franco OL (2019) Recent advances in anti-virulence therapeutic strategies with a focus on dismantling bacterial membrane microdomains, toxin neutralization, quorum-sensing interference and biofilm inhibition. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2019.00074","DOI":"10.3389\/fcimb.2019.00074"},{"key":"4817_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01069","author":"JD Forbes","year":"2017","unstructured":"Forbes JD, Knox NC, Ronholm J et al (2017) Metagenomics: the next culture-independent game changer. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2017.01069","journal-title":"Front Microbiol"},{"key":"4817_CR57","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s43441-022-00480-3","volume":"57","author":"P Franco","year":"2023","unstructured":"Franco P, Jain R, Rosenkrands-Lange E et al (2023) Regulatory pathways supporting expedited drug development and approval in ICH member countries. Ther Innov Regul Sci 57:484\u2013514. https:\/\/doi.org\/10.1007\/s43441-022-00480-3","journal-title":"Ther Innov Regul Sci"},{"key":"4817_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14030221","volume":"14","author":"I Gajic","year":"2025","unstructured":"Gajic I, Tomic N, Lukovic B et al (2025) A comprehensive overview of antibacterial agents for combating multidrug-resistant bacteria: the current landscape, development, future opportunities, and challenges. Antibiotics 14:221. https:\/\/doi.org\/10.3390\/antibiotics14030221","journal-title":"Antibiotics"},{"key":"4817_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1331062","author":"A Gangwal","year":"2024","unstructured":"Gangwal A, Ansari A, Ahmad I et al (2024) Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1331062","journal-title":"Front Pharmacol"},{"key":"4817_CR60","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Trejo JJ, Ortega R, Zarco-Zavala M (2021) Putative repurposing of lamivudine, a nucleoside\/nucleotide analogue and antiretroviral to improve the outcome of cancer and COVID-19 patients. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.664794","DOI":"10.3389\/fonc.2021.664794"},{"key":"4817_CR61","doi-asserted-by":"publisher","unstructured":"Gholamian S, Baghaee P, Doroudian M (2025) Nanotechnology in gene editing: pioneering CRISPR\u2010cas delivery systems to tackle antibiotic resistance. Adv Ther (Weinh). https:\/\/doi.org\/10.1002\/adtp.202400412","DOI":"10.1002\/adtp.202400412"},{"key":"4817_CR62","doi-asserted-by":"publisher","unstructured":"Gholap AD, Khuspe PR, Pardeshi SR, et al (2025) Achieving optimal health with host\u2010directed therapies (HDTs) in infectious diseases\u2014a new horizon. Adv Ther (Weinh). https:\/\/doi.org\/10.1002\/adtp.202400169","DOI":"10.1002\/adtp.202400169"},{"key":"4817_CR63","doi-asserted-by":"crossref","unstructured":"Ghosh K, Sands D (2025) Immunomodulatory effects of microbiome-derived therapies, pp. 97\u2013134","DOI":"10.1007\/978-981-95-2104-3_4"},{"key":"4817_CR64","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s40121-020-00314-5","volume":"9","author":"DR Giacobbe","year":"2020","unstructured":"Giacobbe DR, Dettori S, Di Bella S et al (2020) Bezlotoxumab for preventing recurrent Clostridioides difficile infection: a narrative review from pathophysiology to clinical studies. Infect Dis Ther 9:481\u2013494. https:\/\/doi.org\/10.1007\/s40121-020-00314-5","journal-title":"Infect Dis Ther"},{"key":"4817_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02409","author":"L Grassi","year":"2017","unstructured":"Grassi L, Maisetta G, Esin S, Batoni G (2017) Combination strategies to enhance the efficacy of antimicrobial peptides against bacterial biofilms. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2017.02409","journal-title":"Front Microbiol"},{"key":"4817_CR66","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s13346-020-00736-1","volume":"10","author":"C G\u00fcnday","year":"2020","unstructured":"G\u00fcnday C, Anand S, Gencer HB et al (2020) Ciprofloxacin-loaded polymeric nanoparticles incorporated electrospunfibers for drug delivery in tissue engineering applications. Drug Deliv Transl Res 10:706\u2013720. https:\/\/doi.org\/10.1007\/s13346-020-00736-1","journal-title":"Drug Deliv Transl Res"},{"key":"4817_CR67","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.xphs.2024.12.011","volume":"114","author":"RK Gupta","year":"2025","unstructured":"Gupta RK (2025) The vital role of biological standardization in ensuring efficacy and safety of biological products \u2013 historical perspectives. J Pharm Sci 114:690\u2013700. https:\/\/doi.org\/10.1016\/j.xphs.2024.12.011","journal-title":"J Pharm Sci"},{"key":"4817_CR68","doi-asserted-by":"crossref","unstructured":"Gupta U, Pranav A, Kohli A, et al (2024) The contribution of artificial intelligence to drug discovery: current progress and prospects for the future, pp. 1\u201323","DOI":"10.1007\/978-981-99-9621-6_1"},{"key":"4817_CR69","doi-asserted-by":"publisher","unstructured":"Haines MEK, Hodges FE, Nale JY, et al (2021) Analysis of selection methods to develop novel phage therapy cocktails against antimicrobial resistant clinical isolates of bacteria. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2021.613529","DOI":"10.3389\/fmicb.2021.613529"},{"key":"4817_CR70","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01963-19","author":"JC Hamrick","year":"2020","unstructured":"Hamrick JC, Docquier J-D, Uehara T et al (2020) VNRX-5133 (Taniborbactam), a broad-spectrum inhibitor of serine- and Metallo-\u03b2-Lactamases, restores activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.01963-19","journal-title":"Antimicrob Agents Chemother"},{"key":"4817_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13080786","volume":"13","author":"S Hattab","year":"2024","unstructured":"Hattab S, Ma AH, Tariq Z et al (2024) Rapid phenotypic and genotypic antimicrobial susceptibility testing approaches for use in the clinical laboratory. Antibiotics 13:786. https:\/\/doi.org\/10.3390\/antibiotics13080786","journal-title":"Antibiotics"},{"key":"4817_CR72","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/BTT.S381237","volume":"16","author":"Z Hibstu","year":"2022","unstructured":"Hibstu Z, Belew H, Akelew Y, Mengist HM (2022) Phage therapy: a different approach to fight bacterial infections. Biologics 16:173\u2013186. https:\/\/doi.org\/10.2147\/BTT.S381237","journal-title":"Biologics"},{"key":"4817_CR73","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/1040841X.2021.1962803","volume":"48","author":"MKY Ho","year":"2022","unstructured":"Ho MKY, Zhang P, Chen X et al (2022) Bacteriophage endolysins against gram-positive bacteria, an overview on the clinical development and recent advances on the delivery and formulation strategies. Crit Rev Microbiol 48:303\u2013326. https:\/\/doi.org\/10.1080\/1040841X.2021.1962803","journal-title":"Crit Rev Microbiol"},{"key":"4817_CR74","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.bioactmat.2022.03.011","volume":"18","author":"J Hu","year":"2022","unstructured":"Hu J, Ding Y, Tao B et al (2022) Surface modification of titanium substrate via combining photothermal therapy and quorum-sensing-inhibition strategy for improving osseointegration and treating biofilm-associated bacterial infection. Bioact Mater 18:228\u2013241. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.03.011","journal-title":"Bioact Mater"},{"key":"4817_CR75","doi-asserted-by":"publisher","DOI":"10.5582\/ddt.2025.01028","volume":"19","author":"S Hu","year":"2025","unstructured":"Hu S, Yu H, Gao J (2025) Gepotidacin: the first-in-class triazaacenaphthylene antibiotic approved for the treatment of uncomplicated urinary tract infections. Drug Discov Ther 19:2025.01028. https:\/\/doi.org\/10.5582\/ddt.2025.01028","journal-title":"Drug Discov Ther"},{"key":"4817_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/ph18020206","volume":"18","author":"Y-S Huang","year":"2025","unstructured":"Huang Y-S, Zhou H (2025) Breakthrough advances in beta-lactamase inhibitors: new synthesized compounds and mechanisms of action against drug-resistant bacteria. Pharmaceuticals (Basel) 18:206. https:\/\/doi.org\/10.3390\/ph18020206","journal-title":"Pharmaceuticals (Basel)"},{"key":"4817_CR77","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1007\/s13346-021-00954-1","volume":"11","author":"Z Huang","year":"2021","unstructured":"Huang Z, K\u0142odzi\u0144ska SN, Wan F, Nielsen HM (2021) Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections. Drug Deliv Transl Res 11:1634\u20131654. https:\/\/doi.org\/10.1007\/s13346-021-00954-1","journal-title":"Drug Deliv Transl Res"},{"key":"4817_CR78","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3947\/ic.2021.0093","volume":"53","author":"S Hwang","year":"2021","unstructured":"Hwang S, Kwon KT (2021) Core elements for successful implementation of antimicrobial stewardship programs. Infect Chemother 53:421. https:\/\/doi.org\/10.3947\/ic.2021.0093","journal-title":"Infect Chemother"},{"key":"4817_CR79","doi-asserted-by":"publisher","unstructured":"Inoue H (2019) Strategic approach for combating antimicrobial resistance (AMR). Glob Health Med 1:61\u201364. https:\/\/doi.org\/10.35772\/ghm.2019.01026","DOI":"10.35772\/ghm.2019.01026"},{"key":"4817_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27123832","volume":"27","author":"Z Iqbal","year":"2022","unstructured":"Iqbal Z, Sun J, Yang H et al (2022) Recent developments to cope the antibacterial resistance via \u03b2-lactamase inhibition. Molecules 27:3832. https:\/\/doi.org\/10.3390\/molecules27123832","journal-title":"Molecules"},{"key":"4817_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10020199","volume":"10","author":"HR Jahantigh","year":"2022","unstructured":"Jahantigh HR, Faezi S, Habibi M et al (2022) The candidate antigens to achieving an effective vaccine against Staphylococcus aureus. Vaccines 10:199. https:\/\/doi.org\/10.3390\/vaccines10020199","journal-title":"Vaccines"},{"key":"4817_CR82","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jcis.2024.02.155","volume":"663","author":"H Jiang","year":"2024","unstructured":"Jiang H, Fang W, Xu S et al (2024) Synergistic quorum sensing inhibition and mild-temperature photothermal therapy of integrated nanoplatform for implant-associated biofilm infections. J Colloid Interface Sci 663:143\u2013156. https:\/\/doi.org\/10.1016\/j.jcis.2024.02.155","journal-title":"J Colloid Interface Sci"},{"key":"4817_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052655","volume":"25","author":"E Juszczuk-Kubiak","year":"2024","unstructured":"Juszczuk-Kubiak E (2024) Molecular aspects of the functioning of pathogenic bacteria biofilm based on quorum sensing (QS) signal-response system and innovative non-antibiotic strategies for their elimination. Int J Mol Sci 25:2655. https:\/\/doi.org\/10.3390\/ijms25052655","journal-title":"Int J Mol Sci"},{"key":"4817_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12101504","volume":"12","author":"M Kanan","year":"2023","unstructured":"Kanan M, Ramadan M, Haif H et al (2023) RETRACTED: empowering low- and middle-income countries to combat AMR by minimal use of antibiotics: a way forward. Antibiotics 12:1504. https:\/\/doi.org\/10.3390\/antibiotics12101504","journal-title":"Antibiotics"},{"key":"4817_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2024.107228","volume":"309","author":"S-J Kang","year":"2024","unstructured":"Kang S-J, Kim D-H, Lee B-J (2024) Metallo-\u03b2-lactamase inhibitors: a continuing challenge for combating antibiotic resistance. Biophys Chem 309:107228. https:\/\/doi.org\/10.1016\/j.bpc.2024.107228","journal-title":"Biophys Chem"},{"key":"4817_CR86","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.3390\/s25175293","volume":"25","author":"K Kao","year":"2025","unstructured":"Kao K, Alocilja EC (2025) Integrated sample to detection of carbapenem-resistant bacteria extracted from water samples using a portable gold nanoparticle-based biosensor. Sensors 25:5293. https:\/\/doi.org\/10.3390\/s25175293","journal-title":"Sensors"},{"key":"4817_CR87","unstructured":"K Karnchanapandh (2023) Bezlotoxumab binding specificity to toxin b of Clostridium difficile. Chulalongkorn University"},{"key":"4817_CR88","doi-asserted-by":"crossref","unstructured":"Kaur G, Trivedi P (2024) Strategic defenders: antimicrobial peptides and their impact on the innate immunity. In: Evolution of Antimicrobial Peptides. Springer Nature Switzerland, Cham, pp. 221\u2013273","DOI":"10.1007\/978-3-031-67515-7_9"},{"key":"4817_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.aimed.2025.100529","volume":"12","author":"H Khude","year":"2025","unstructured":"Khude H, Shende P (2025) AI-driven clinical decision support systems: revolutionizing medication selection and personalized drug therapy. Adv Integr Med 12:100529. https:\/\/doi.org\/10.1016\/j.aimed.2025.100529","journal-title":"Adv Integr Med"},{"key":"4817_CR90","doi-asserted-by":"publisher","unstructured":"Kolawole TO, Mustapha AY, Mbata AO, et al (2023) Innovative strategies for reducing antimicrobial resistance: a review of global policy and practice. J Front Multidiscip Res 4:25\u201338. https:\/\/doi.org\/10.54660\/.IJFMR.2023.4.1.25-38","DOI":"10.54660\/.IJFMR.2023.4.1.25-38"},{"key":"4817_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/scipharm86040043","volume":"86","author":"J Krau\u00df","year":"2018","unstructured":"Krau\u00df J, Bracher F (2018) Pharmacokinetic enhancers (boosters)\u2014escort for drugs against degrading enzymes and beyond. Sci Pharm 86:43. https:\/\/doi.org\/10.3390\/scipharm86040043","journal-title":"Sci Pharm"},{"key":"4817_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00996-0","volume":"19","author":"A Kumar","year":"2021","unstructured":"Kumar A, Choudhary A, Kaur H et al (2021) Metal-based nanoparticles, sensors, and their multifaceted application in food packaging. J Nanobiotechnol 19:256. https:\/\/doi.org\/10.1186\/s12951-021-00996-0","journal-title":"J Nanobiotechnol"},{"key":"4817_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-025-04800-1","volume":"21","author":"LS Kumari","year":"2025","unstructured":"Kumari LS, Siriwardhana DM, Liyanapathirana V et al (2025) Rapid whole genome sequencing for AMR surveillance in low- and middle-income countries: oxford nanopore technology reveals multidrug-resistant Enterobacter cloacae complex from dairy farms in Sri Lanka. BMC Vet Res 21:351. https:\/\/doi.org\/10.1186\/s12917-025-04800-1","journal-title":"BMC Vet Res"},{"key":"4817_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12091362","volume":"12","author":"H Lade","year":"2023","unstructured":"Lade H, Kim J-S (2023) Molecular determinants of \u03b2-lactam resistance in methicillin-resistant Staphylococcus aureus (MRSA): an updated review. Antibiotics Basel 12:1362. https:\/\/doi.org\/10.3390\/antibiotics12091362","journal-title":"Antibiotics Basel"},{"key":"4817_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-025-04504-z","volume":"12","author":"P Lasch","year":"2025","unstructured":"Lasch P, Beyer W, Bosch A et al (2025) A MALDI-ToF mass spectrometry database for identification and classification of highly pathogenic bacteria. Sci Data 12:187. https:\/\/doi.org\/10.1038\/s41597-025-04504-z","journal-title":"Sci Data"},{"key":"4817_CR96","doi-asserted-by":"publisher","unstructured":"Laverty H, Meulien P (2019) The Innovative Medicines Initiative\u2009\u2212\u200910 Years of Public-Private Collaboration. Front Med (Lausanne). https:\/\/doi.org\/10.3389\/fmed.2019.00275","DOI":"10.3389\/fmed.2019.00275"},{"key":"4817_CR97","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/antibiotics10010091","volume":"10","author":"C Lee","year":"2021","unstructured":"Lee C, Bhakta S (2021) The prospect of repurposing immunomodulatory drugs for adjunctive chemotherapy against tuberculosis: a critical review. Antibiotics 10:91. https:\/\/doi.org\/10.3390\/antibiotics10010091","journal-title":"Antibiotics"},{"key":"4817_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14060587","volume":"14","author":"P Leroux","year":"2025","unstructured":"Leroux P, Bornet C, Bolla J-M, Cohen A (2025) Challenges of carbapenem-resistant Enterobacteriaceae in the development of new \u03b2-lactamase inhibitors and antibiotics. Antibiotics (Basel) 14:587. https:\/\/doi.org\/10.3390\/antibiotics14060587","journal-title":"Antibiotics (Basel)"},{"key":"4817_CR99","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/jac\/dkae438","volume":"80","author":"JJ Levenfors","year":"2025","unstructured":"Levenfors JJ, Bjerketorp J, Guss B et al (2025) Repurposing zidovudine and 5-fluoro-2\u2032-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity\u2013reducing agent uridine. J Antimicrob Chemother 80:509\u2013517. https:\/\/doi.org\/10.1093\/jac\/dkae438","journal-title":"J Antimicrob Chemother"},{"key":"4817_CR100","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1042\/BST20231289","volume":"52","author":"JM Lewis","year":"2024","unstructured":"Lewis JM, Williams J, Sagona AP (2024) Making the leap from technique to treatment \u2014 genetic engineering is paving the way for more efficient phage therapy. Biochem Soc Trans 52:1373\u20131384. https:\/\/doi.org\/10.1042\/BST20231289","journal-title":"Biochem Soc Trans"},{"key":"4817_CR101","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7150\/ntno.25565","volume":"2","author":"E Li","year":"2018","unstructured":"Li E, Yang Y, Hao G et al (2018) Multifunctional magnetic mesoporous silica nanoagents for in vivo enzyme-responsive drug delivery and MR imaging. Nanotheranostics 2:233\u2013242. https:\/\/doi.org\/10.7150\/ntno.25565","journal-title":"Nanotheranostics"},{"key":"4817_CR102","doi-asserted-by":"publisher","DOI":"10.1002\/mba2.70031","author":"M Li","year":"2025","unstructured":"Li M, Luo Y, Li W et al (2025) Modular nanosensing platforms for tuberculosis and beyond: engineering biomaterials toward cross\u2010pathogen diagnostic universality. MedComm - Biomater Appl. https:\/\/doi.org\/10.1002\/mba2.70031","journal-title":"MedComm - Biomater Appl"},{"key":"4817_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2025.102936","volume":"18","author":"A Liang","year":"2025","unstructured":"Liang A, Wu X, Zhu Y et al (2025) Targeted next-generation sequencing (tNGS): an upcoming application for pathogen identification in clinical diagnosis. J Infect Public Health 18:102936. https:\/\/doi.org\/10.1016\/j.jiph.2025.102936","journal-title":"J Infect Public Health"},{"key":"4817_CR104","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.7150\/thno.56205","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu Y, Tong Z, Shi J et al (2021a) Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria. Theranostics 11:4910\u20134928. https:\/\/doi.org\/10.7150\/thno.56205","journal-title":"Theranostics"},{"key":"4817_CR105","doi-asserted-by":"publisher","first-page":"7878","DOI":"10.1039\/D1TB01316E","volume":"9","author":"H Liu","year":"2021","unstructured":"Liu H, Zhong W, Zhang X et al (2021b) Nanomedicine as a promising strategy for the theranostics of infectious diseases. J Mater Chem B 9:7878\u20137908. https:\/\/doi.org\/10.1039\/D1TB01316E","journal-title":"J Mater Chem B"},{"key":"4817_CR106","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.4c00989","volume":"125","author":"L Lombardi","year":"2025","unstructured":"Lombardi L, Del Genio V, Albericio F, Williams DR (2025) Advances in peptidomimetics for next-generation therapeutics: strategies, modifications, and applications. Chem Rev 125:7099\u20137166. https:\/\/doi.org\/10.1021\/acs.chemrev.4c00989","journal-title":"Chem Rev"},{"key":"4817_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.996264","author":"H Lv","year":"2022","unstructured":"Lv H, Liu J, Wang Y et al (2022) Upconversion nanoparticles and its based photodynamic therapy for antibacterial applications: a state-of-the-art review. Front Chem. https:\/\/doi.org\/10.3389\/fchem.2022.996264","journal-title":"Front Chem"},{"key":"4817_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13010172","volume":"13","author":"J Ma","year":"2025","unstructured":"Ma J, Lu Z (2025) Developing a versatile arsenal: novel antimicrobials as offensive tools against pathogenic bacteria. Microorganisms 13:172. https:\/\/doi.org\/10.3390\/microorganisms13010172","journal-title":"Microorganisms"},{"key":"4817_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/mi14020459","volume":"14","author":"M MacKenzie","year":"2023","unstructured":"MacKenzie M, Argyropoulos C (2023) An introduction to nanopore sequencing: past, present, and future considerations. Micromach (Basel) 14:459. https:\/\/doi.org\/10.3390\/mi14020459","journal-title":"Micromach (Basel)"},{"key":"4817_CR110","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s12088-024-01439-8","volume":"65","author":"S Mangal","year":"2025","unstructured":"Mangal S, Singh V, Chhibber S, Harjai K (2025) Headway in synthetic chemistry: a gateway for antimicrobial Trojan horse strategy for drug repurposing against multi-drug resistant Pseudomonas aeruginosa. Indian J Microbiol 65:798\u2013819. https:\/\/doi.org\/10.1007\/s12088-024-01439-8","journal-title":"Indian J Microbiol"},{"key":"4817_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/epidemiologia6020021","volume":"6","author":"A Marino","year":"2025","unstructured":"Marino A, Maniaci A, Lentini M et al (2025a) The global burden of multidrug-resistant bacteria. Epidemiologia 6:21. https:\/\/doi.org\/10.3390\/epidemiologia6020021","journal-title":"Epidemiologia"},{"key":"4817_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14101011","volume":"14","author":"A Marino","year":"2025","unstructured":"Marino A, Stracquadanio S, Cosentino F et al (2025b) Phage to ESKAPE: personalizing therapy for MDR infections\u2014a comprehensive clinical review. Pathogens 14:1011. https:\/\/doi.org\/10.3390\/pathogens14101011","journal-title":"Pathogens"},{"key":"4817_CR113","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/14787210.2019.1561275","volume":"17","author":"C Mathieu","year":"2019","unstructured":"Mathieu C, Pastene B, Cassir N et al (2019) Efficacy and safety of antimicrobial de-escalation as a clinical strategy. Expert Rev Anti Infect Ther 17:79\u201388. https:\/\/doi.org\/10.1080\/14787210.2019.1561275","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4817_CR114","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1021\/acsinfecdis.2c00649","volume":"9","author":"A Mayorga-Ramos","year":"2023","unstructured":"Mayorga-Ramos A, Z\u00fa\u00f1iga-Miranda J, Carrera-Pacheco SE et al (2023) CRISPR-Cas-based antimicrobials: design, challenges, and bacterial mechanisms of resistance. ACS Infect Dis 9:1283\u20131302. https:\/\/doi.org\/10.1021\/acsinfecdis.2c00649","journal-title":"ACS Infect Dis"},{"key":"4817_CR115","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/antibiotics9010032","volume":"9","author":"E Meade","year":"2020","unstructured":"Meade E, Slattery MA, Garvey M (2020) Bacteriocins, potent antimicrobial peptides and the fight against multi drug resistant species: resistance is futile? Antibiotics 9:32. https:\/\/doi.org\/10.3390\/antibiotics9010032","journal-title":"Antibiotics"},{"key":"4817_CR116","doi-asserted-by":"publisher","DOI":"10.1007\/s11274-023-03545-z","volume":"39","author":"H Memariani","year":"2023","unstructured":"Memariani H, Memariani M (2023) Antibiofilm properties of cathelicidin LL-37: an in-depth review. World J Microbiol Biotechnol 39:99. https:\/\/doi.org\/10.1007\/s11274-023-03545-z","journal-title":"World J Microbiol Biotechnol"},{"key":"4817_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10020416","volume":"10","author":"G Mendes","year":"2022","unstructured":"Mendes G, Ramalho JF, Bruschy-Fonseca A et al (2022) Whole-genome sequencing enables molecular characterization of non-clonal group 258 high-risk clones (ST13, ST17, ST147 and ST307) among carbapenem-resistant Klebsiella pneumoniae from a tertiary university hospital centre in Portugal. Microorganisms 10:416. https:\/\/doi.org\/10.3390\/microorganisms10020416","journal-title":"Microorganisms"},{"key":"4817_CR118","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/antibiotics13070623","volume":"13","author":"A Mishra","year":"2024","unstructured":"Mishra A, Aggarwal A, Khan F (2024) Medical device-associated infections caused by biofilm-forming microbial pathogens and controlling strategies. Antibiotics 13:623. https:\/\/doi.org\/10.3390\/antibiotics13070623","journal-title":"Antibiotics"},{"key":"4817_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14010057","volume":"14","author":"SK Mishra","year":"2025","unstructured":"Mishra SK, Akter T, Urmi UL et al (2025) Harnessing non-antibiotic strategies to counter multidrug-resistant clinical pathogens with special reference to antimicrobial peptides and their coatings. Antibiotics 14:57. https:\/\/doi.org\/10.3390\/antibiotics14010057","journal-title":"Antibiotics"},{"key":"4817_CR120","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s40001-023-01275-4","volume":"28","author":"R Mohi-ud-din","year":"2023","unstructured":"Mohi-ud-din R, Chawla A, Sharma P et al (2023) Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects. Eur J Med Res 28:345. https:\/\/doi.org\/10.1186\/s40001-023-01275-4","journal-title":"Eur J Med Res"},{"key":"4817_CR121","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/ijc.34815","volume":"154","author":"J Mora","year":"2024","unstructured":"Mora J, Modak S, Kinsey J et al (2024) < scp>GM-CSF<\/scp>, <scp > G-CSF<\/scp > or no cytokine therapy with < scp>anti-GD2<\/scp> immunotherapy for high-risk neuroblastoma. Int J Cancer 154:1340\u20131364. https:\/\/doi.org\/10.1002\/ijc.34815","journal-title":"Int J Cancer"},{"key":"4817_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering9120774","volume":"9","author":"V Morais","year":"2022","unstructured":"Morais V, Suarez N (2022) Conjugation mechanism for pneumococcal glycoconjugate vaccines: classic and emerging methods. Bioengineering 9:774. https:\/\/doi.org\/10.3390\/bioengineering9120774","journal-title":"Bioengineering"},{"key":"4817_CR123","doi-asserted-by":"publisher","unstructured":"Mukherjee S, Patra D, Maity S, Haldar J (2025) Advancements in antimicrobial biomaterials: new avenues to ameliorate wound infections and implant-associated infections. Curr Indian Sci. https:\/\/doi.org\/10.2174\/012210299X314905241203104146","DOI":"10.2174\/012210299X314905241203104146"},{"key":"4817_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2025.107232","volume":"237","author":"M Mulat","year":"2025","unstructured":"Mulat M, Banicod RJS, Tabassum N et al (2025) Application of artificial intelligence in microbial drug discovery: unlocking new frontiers in biotechnology. J Microbiol Methods 237:107232. https:\/\/doi.org\/10.1016\/j.mimet.2025.107232","journal-title":"J Microbiol Methods"},{"key":"4817_CR125","doi-asserted-by":"publisher","DOI":"10.1007\/s10989-023-10519-0","volume":"29","author":"T Naaz","year":"2023","unstructured":"Naaz T, Lahiri D, Pandit S et al (2023) Antimicrobial peptides against microbial biofilms: efficacy, challenges, and future prospect. Int J Pept Res Ther 29:48. https:\/\/doi.org\/10.1007\/s10989-023-10519-0","journal-title":"Int J Pept Res Ther"},{"key":"4817_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1329330","author":"AM Nafea","year":"2024","unstructured":"Nafea AM, Wang Y, Wang D et al (2024) Application of next-generation sequencing to identify different pathogens. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2023.1329330","journal-title":"Front Microbiol"},{"key":"4817_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14121267","volume":"14","author":"NM Nass","year":"2025","unstructured":"Nass NM, Zaher KA (2025) From methylomes to CRISPR epigenetic editing: new paths in antibiotic resistance. Pathogens 14:1267. https:\/\/doi.org\/10.3390\/pathogens14121267","journal-title":"Pathogens"},{"key":"4817_CR128","doi-asserted-by":"crossref","unstructured":"Nayak A, Satpathy I, Khang A (2026) Employing Ai-powered clinical decision support to revolutionize healthcare: Integrating data analytics with informed diagnostics. In: Revolutionizing Digital Healthcare Through Artificial Intelligence and Automation. Elsevier, pp. 433\u2013446","DOI":"10.1016\/B978-0-443-36434-1.00030-6"},{"key":"4817_CR129","unstructured":"Next generation tools for pathogen surveillance in tropical regions (2026)"},{"key":"4817_CR130","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/14787210.2020.1756775","volume":"18","author":"A Novelli","year":"2020","unstructured":"Novelli A, Del Giacomo P, Rossolini GM, Tumbarello M (2020a) Meropenem\/vaborbactam: a next generation \u03b2-lactam \u03b2-lactamase inhibitor combination. Expert Rev Anti Infect Ther 18:643\u2013655. https:\/\/doi.org\/10.1080\/14787210.2020.1756775","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4817_CR131","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/14787210.2020.1756775","volume":"18","author":"A Novelli","year":"2020","unstructured":"Novelli A, Del Giacomo P, Rossolini GM, Tumbarello M (2020b) Meropenem\/vaborbactam: a next generation \u03b2-lactam \u03b2-lactamase inhibitor combination. Expert Rev Anti Infect Ther 18:643\u2013655. https:\/\/doi.org\/10.1080\/14787210.2020.1756775","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4817_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29163944","volume":"29","author":"JL Ortega-Balleza","year":"2024","unstructured":"Ortega-Balleza JL, V\u00e1zquez-Jim\u00e9nez LK, Ortiz-P\u00e9rez E et al (2024) Current strategy for targeting metallo-\u03b2-lactamase with metal-ion-binding inhibitors. Molecules (Basel) 29:3944. https:\/\/doi.org\/10.3390\/molecules29163944","journal-title":"Molecules (Basel)"},{"key":"4817_CR133","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1021\/acsinfecdis.3c00346","volume":"10","author":"AA Oviatt","year":"2024","unstructured":"Oviatt AA, Gibson EG, Huang J et al (2024) Interactions between Gepotidacin and Escherichia coli gyrase and topoisomerase IV: genetic and biochemical evidence for well-balanced dual-targeting. ACS Infect Dis 10:1137\u20131151. https:\/\/doi.org\/10.1021\/acsinfecdis.3c00346","journal-title":"ACS Infect Dis"},{"key":"4817_CR134","doi-asserted-by":"publisher","first-page":"S529","DOI":"10.1093\/cid\/ciz825","volume":"69","author":"MGP Page","year":"2019","unstructured":"Page MGP (2019) The role of iron and siderophores in infection, and the development of siderophore antibiotics. Clin Infect Dis 69:S529\u2013S537. https:\/\/doi.org\/10.1093\/cid\/ciz825","journal-title":"Clin Infect Dis"},{"key":"4817_CR135","doi-asserted-by":"publisher","unstructured":"Palani N, Mendonce KC, Syed Altaf RR, et al (2025) Next-generation smart wound dressings: AI integration, biosensors, and electrospun nanofibers for chronic wound therapy. J Biomater Sci Polym Ed 1\u201351. https:\/\/doi.org\/10.1080\/09205063.2025.2540362","DOI":"10.1080\/09205063.2025.2540362"},{"key":"4817_CR136","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/bit.27760","volume":"118","author":"H Panlilio","year":"2021","unstructured":"Panlilio H, Rice CV (2021) The role of extracellular DNA in the formation, architecture, stability, and treatment of bacterial biofilms. Biotechnol Bioeng 118:2129\u20132141. https:\/\/doi.org\/10.1002\/bit.27760","journal-title":"Biotechnol Bioeng"},{"key":"4817_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14020207","volume":"14","author":"N Parvin","year":"2025","unstructured":"Parvin N, Joo SW, Mandal TK (2025) Nanomaterial-based strategies to combat antibiotic resistance: mechanisms and applications. Antibiotics 14:207. https:\/\/doi.org\/10.3390\/antibiotics14020207","journal-title":"Antibiotics"},{"key":"4817_CR138","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1039\/C9OB02605C","volume":"18","author":"L Peilleron","year":"2020","unstructured":"Peilleron L, Cariou K (2020) Synthetic approaches towards avibactam and other diazabicyclooctane \u03b2-lactamase inhibitors. Org Biomol Chem 18:830\u2013844. https:\/\/doi.org\/10.1039\/C9OB02605C","journal-title":"Org Biomol Chem"},{"key":"4817_CR139","doi-asserted-by":"publisher","unstructured":"Pires IS, Hammond PT, Irvine DJ (2021) Engineering strategies for immunomodulatory cytokine therapies: challenges and clinical progress. Adv Ther (Weinh). https:\/\/doi.org\/10.1002\/adtp.202100035","DOI":"10.1002\/adtp.202100035"},{"key":"4817_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168937","volume":"22","author":"M Podlacha","year":"2021","unstructured":"Podlacha M, Grabowski \u0141, Kosznik-Kaw\u015bnicka K et al (2021) Interactions of bacteriophages with animal and human organisms\u2014safety issues in the light of phage therapy. Int J Mol Sci 22:8937. https:\/\/doi.org\/10.3390\/ijms22168937","journal-title":"Int J Mol Sci"},{"key":"4817_CR141","first-page":"475","volume-title":"Advanced techniques in diagnostic microbiology","author":"MA Poritz","year":"2018","unstructured":"Poritz MA, Lingenfelter B (2018) Multiplex PCR for detection and identification of microbial pathogens. Advanced techniques in diagnostic microbiology. Springer International Publishing, Cham, pp 475\u2013493"},{"key":"4817_CR142","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1021\/acs.biomac.1c01614","volume":"23","author":"D Pranantyo","year":"2022","unstructured":"Pranantyo D, Zhang K, Si Z et al (2022) Smart multifunctional polymer systems as alternatives or supplements of antibiotics to overcome bacterial resistance. Biomacromol 23:1873\u20131891. https:\/\/doi.org\/10.1021\/acs.biomac.1c01614","journal-title":"Biomacromol"},{"key":"4817_CR143","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1099\/jmm.0.001144","volume":"69","author":"CR Proctor","year":"2020","unstructured":"Proctor CR, McCarron PA, Ternan NG (2020) Furanone quorum-sensing inhibitors with potential as novel therapeutics against Pseudomonas aeruginosa. J Med Microbiol 69:195\u2013206. https:\/\/doi.org\/10.1099\/jmm.0.001144","journal-title":"J Med Microbiol"},{"key":"4817_CR144","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.mjafi.2024.07.006","volume":"81","author":"B Puri","year":"2025","unstructured":"Puri B, Vaishya R, Vaish A (2025) Antimicrobial resistance: current challenges and future directions. Med J Armed Forces India 81:247\u2013258. https:\/\/doi.org\/10.1016\/j.mjafi.2024.07.006","journal-title":"Med J Armed Forces India"},{"key":"4817_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14020185","volume":"14","author":"FS Rasquel-Oliveira","year":"2025","unstructured":"Rasquel-Oliveira FS, Ribeiro JM, Martelossi-Cebinelli G et al (2025) Staphylococcus aureus in inflammation and pain: update on pathologic mechanisms. Pathogens 14:185. https:\/\/doi.org\/10.3390\/pathogens14020185","journal-title":"Pathogens"},{"key":"4817_CR146","doi-asserted-by":"crossref","unstructured":"Reid L (2020) Antimicrobial resistance and social inequalities in health: considerations of justice, pp. 257\u2013278","DOI":"10.1007\/978-3-030-27874-8_16"},{"key":"4817_CR147","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s44222-024-00260-8","volume":"3","author":"J Ritmejeris","year":"2024","unstructured":"Ritmejeris J, Chen X, Dekker C (2024) Single-molecule protein sequencing with nanopores. Nat Rev Bioeng 3:303\u2013316. https:\/\/doi.org\/10.1038\/s44222-024-00260-8","journal-title":"Nat Rev Bioeng"},{"key":"4817_CR148","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/femsre\/fuaa016","volume":"44","author":"A Roberts","year":"2020","unstructured":"Roberts A, Barrangou R (2020) Applications of CRISPR-Cas systems in lactic acid bacteria. FEMS Microbiol Rev 44:523\u2013537. https:\/\/doi.org\/10.1093\/femsre\/fuaa016","journal-title":"FEMS Microbiol Rev"},{"key":"4817_CR149","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1080\/17460441.2025.2499123","volume":"20","author":"M Ronzetti","year":"2025","unstructured":"Ronzetti M, Simeonov A (2025) A comprehensive update on the application of high-throughput fluorescence imaging for novel drug discovery. Expert Opin Drug Discov 20:785\u2013797. https:\/\/doi.org\/10.1080\/17460441.2025.2499123","journal-title":"Expert Opin Drug Discov"},{"key":"4817_CR150","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1021\/acs.analchem.2c04529","volume":"95","author":"A Rubio-Monterde","year":"2023","unstructured":"Rubio-Monterde A, Quesada-Gonz\u00e1lez D, Merko\u00e7i A (2023) Toward integrated molecular lateral flow diagnostic tests using advanced micro- and nanotechnology. Anal Chem 95:468\u2013489. https:\/\/doi.org\/10.1021\/acs.analchem.2c04529","journal-title":"Anal Chem"},{"key":"4817_CR151","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/bacteria4030046","volume":"4","author":"S Rugarabamu","year":"2025","unstructured":"Rugarabamu S, Mwanyika G (2025) Biotechnological innovations to combat antimicrobial resistance and advance global health equity. Bacteria Basel 4:46. https:\/\/doi.org\/10.3390\/bacteria4030046","journal-title":"Bacteria Basel"},{"key":"4817_CR152","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02476-16","author":"M Ruggiero","year":"2017","unstructured":"Ruggiero M, Papp-Wallace KM, Taracila MA et al (2017) Exploring the landscape of Diazabicyclooctane (DBO) inhibition: Avibactam inactivation of PER-2 \u03b2-Lactamase. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.02476-16","journal-title":"Antimicrob Agents Chemother"},{"key":"4817_CR153","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30122542","volume":"30","author":"I Rykowska","year":"2025","unstructured":"Rykowska I, Nowak I, Nowak R, Micha\u0142kiewicz O (2025) Biodegradable contact lenses for targeted ocular drug delivery: recent advances, clinical applications, and translational perspectives. Molecules 30:2542. https:\/\/doi.org\/10.3390\/molecules30122542","journal-title":"Molecules"},{"key":"4817_CR154","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2174\/1389450121666200924113740","volume":"22","author":"NB Sadeer","year":"2021","unstructured":"Sadeer NB, Mahomoodally MF (2021) Antibiotic potentiation of natural products: a promising target to fight pathogenic bacteria. Curr Drug Targets 22:555\u2013572. https:\/\/doi.org\/10.2174\/1389450121666200924113740","journal-title":"Curr Drug Targets"},{"key":"4817_CR155","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1093\/jac\/dkac233","volume":"77","author":"HS Sader","year":"2022","unstructured":"Sader HS, Mendes RE, Duncan LR et al (2022) Antimicrobial activity of cefepime\/zidebactam (WCK 5222), a \u03b2-lactam\/\u03b2-lactam enhancer combination, against clinical isolates of gram-negative bacteria collected worldwide (2018\u201319). J Antimicrob Chemother 77:2642\u20132649. https:\/\/doi.org\/10.1093\/jac\/dkac233","journal-title":"J Antimicrob Chemother"},{"key":"4817_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.661195","author":"A Sahoo","year":"2021","unstructured":"Sahoo A, Swain SS, Behera A et al (2021) Antimicrobial peptides derived from insects offer a novel therapeutic option to combat biofilm: A review. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2021.661195","journal-title":"Front Microbiol"},{"key":"4817_CR157","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2174\/1389201024666221104142457","volume":"24","author":"R Sahu","year":"2023","unstructured":"Sahu R, Singh AK, Kumar A et al (2023) Bacteriophages concept and applications: a review on phage therapy. Curr Pharm Biotechnol 24:1245\u20131264. https:\/\/doi.org\/10.2174\/1389201024666221104142457","journal-title":"Curr Pharm Biotechnol"},{"key":"4817_CR158","doi-asserted-by":"publisher","first-page":"S538","DOI":"10.1093\/cid\/ciz826","volume":"69","author":"T Sato","year":"2019","unstructured":"Sato T, Yamawaki K (2019) Cefiderocol: discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin. Clin Infect Dis 69:S538\u2013S543. https:\/\/doi.org\/10.1093\/cid\/ciz826","journal-title":"Clin Infect Dis"},{"key":"4817_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050420","volume":"9","author":"C Scelfo","year":"2021","unstructured":"Scelfo C, Menzella F, Fontana M et al (2021) Pneumonia and invasive pneumococcal diseases: the role of pneumococcal conjugate vaccine in the era of multi-drug resistance. Vaccines (Basel) 9:420. https:\/\/doi.org\/10.3390\/vaccines9050420","journal-title":"Vaccines (Basel)"},{"key":"4817_CR160","doi-asserted-by":"publisher","unstructured":"Schurer M, Patel R, van Keep M, et al (2023) Recent advances in addressing the market failure of new antimicrobials: learnings from NICE\u2019s subscription-style payment model. Front Med Technol. https:\/\/doi.org\/10.3389\/fmedt.2023.1010247","DOI":"10.3389\/fmedt.2023.1010247"},{"key":"4817_CR162","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/1568009621666211206102942","volume":"22","author":"P Shah","year":"2022","unstructured":"Shah P, Shende P (2022) Biomacromolecule-functionalized nanoparticle-based conjugates for potentiation of anticancer therapy. Curr Cancer Drug Targets 22:31\u201348. https:\/\/doi.org\/10.2174\/1568009621666211206102942","journal-title":"Curr Cancer Drug Targets"},{"key":"4817_CR163","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.3390\/polym15173597","volume":"15","author":"AK Shakya","year":"2023","unstructured":"Shakya AK, Al-Sulaibi M, Naik RR et al (2023) Review on PLGA polymer based nanoparticles with antimicrobial properties and their application in various medical conditions or infections. Polym (Basel) 15:3597. https:\/\/doi.org\/10.3390\/polym15173597","journal-title":"Polym (Basel)"},{"key":"4817_CR164","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa403","author":"D Sheka","year":"2021","unstructured":"Sheka D, Alabi N, Gordon PMK (2021) Oxford nanopore sequencing in clinical microbiology and infection diagnostics. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbaa403","journal-title":"Brief Bioinform"},{"key":"4817_CR165","doi-asserted-by":"publisher","DOI":"10.1080\/1061186X.2025.2554758","author":"P Shetty","year":"2025","unstructured":"Shetty P, Koland M, Saoji SD et al (2025) Bioengineered nanocomposite bacitracin zinc-loaded chitosan microspheres containing keratin\/gelatine films for wound healing. J Drug Target. https:\/\/doi.org\/10.1080\/1061186X.2025.2554758","journal-title":"J Drug Target"},{"key":"4817_CR166","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1038\/s41598-018-21520-9","volume":"8","author":"X Shi","year":"2018","unstructured":"Shi X, Kadiyala U, VanEpps JS, Yau S-T (2018) Culture-free bacterial detection and identification from blood with rapid, phenotypic, antibiotic susceptibility testing. Sci Rep 8:3416. https:\/\/doi.org\/10.1038\/s41598-018-21520-9","journal-title":"Sci Rep"},{"key":"4817_CR167","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17111438","volume":"17","author":"L Shqair","year":"2025","unstructured":"Shqair L, Draw I, Maya T et al (2025) Advances in cell-mediated drug delivery for dermatologic diseases: mechanisms and current applications. Pharmaceutics 17:1438. https:\/\/doi.org\/10.3390\/pharmaceutics17111438","journal-title":"Pharmaceutics"},{"key":"4817_CR168","doi-asserted-by":"publisher","first-page":"i32","DOI":"10.1093\/jac\/dkae279","volume":"79","author":"CC Simons","year":"2024","unstructured":"Simons CC, Capraro GA (2024) Barriers to implementation of rapid identification and antimicrobial susceptibility testing technologies in the clinical microbiology laboratory: an American perspective. J Antimicrob Chemother 79:i32\u2013i36. https:\/\/doi.org\/10.1093\/jac\/dkae279","journal-title":"J Antimicrob Chemother"},{"key":"4817_CR169","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/microorganisms8050639","volume":"8","author":"A Simons","year":"2020","unstructured":"Simons A, Alhanout K, Duval RE (2020) Bacteriocins, antimicrobial peptides from bacterial origin: overview of their biology and their impact against multidrug-resistant bacteria. Microorganisms 8:639. https:\/\/doi.org\/10.3390\/microorganisms8050639","journal-title":"Microorganisms"},{"key":"4817_CR170","doi-asserted-by":"crossref","unstructured":"Singh V (2024) Theranostics: integrated diagnostics and therapy using nanomedicine, pp. 505\u2013530","DOI":"10.1007\/978-3-031-72467-1_17"},{"key":"4817_CR171","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1080\/14760584.2020.1825948","volume":"19","author":"M Slack","year":"2020","unstructured":"Slack M, Esposito S, Haas H et al (2020) Haemophilus influenzae type b disease in the era of conjugate vaccines: critical factors for successful eradication. Expert Rev Vaccines 19:903\u2013917. https:\/\/doi.org\/10.1080\/14760584.2020.1825948","journal-title":"Expert Rev Vaccines"},{"key":"4817_CR172","doi-asserted-by":"publisher","DOI":"10.3389\/fsci.2024.1298248","author":"MJ Struelens","year":"2024","unstructured":"Struelens MJ, Ludden C, Werner G et al (2024) Real-time genomic surveillance for enhanced control of infectious diseases and antimicrobial resistance. Front Sci. https:\/\/doi.org\/10.3389\/fsci.2024.1298248","journal-title":"Front Sci"},{"key":"4817_CR173","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaf470","author":"A Talianu","year":"2025","unstructured":"Talianu A, Fraser-Krauss O, Bolton W et al (2025) Artificial intelligence for improving decision-making in bacterial infection management: a narrative review. J Antimicrob Chemother. https:\/\/doi.org\/10.1093\/jac\/dkaf470","journal-title":"J Antimicrob Chemother"},{"key":"4817_CR174","doi-asserted-by":"publisher","unstructured":"Teklemariam AD, Al Hindi R, Qadri I, et al (2023) Phage cocktails\u2014an emerging approach for the control of bacterial infection with major emphasis on foodborne pathogens. Biotechnol Genet Eng Rev. https:\/\/doi.org\/10.1080\/02648725.2023.2178870","DOI":"10.1080\/02648725.2023.2178870"},{"key":"4817_CR175","doi-asserted-by":"publisher","DOI":"10.3390\/gels9010035","volume":"9","author":"K Thirupathi","year":"2022","unstructured":"Thirupathi K, Raorane CJ, Ramkumar V et al (2022) Update on chitosan-based hydrogels: preparation, characterization, and its antimicrobial and antibiofilm applications. Gels 9:35. https:\/\/doi.org\/10.3390\/gels9010035","journal-title":"Gels"},{"key":"4817_CR176","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00564-19","author":"CL Tooke","year":"2019","unstructured":"Tooke CL, Hinchliffe P, Lang PA et al (2019) Molecular basis of class A \u03b2-Lactamase inhibition by Relebactam. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00564-19","journal-title":"Antimicrob Agents Chemother"},{"key":"4817_CR177","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.procbio.2023.02.022","volume":"129","author":"A Upadhyay","year":"2023","unstructured":"Upadhyay A, Pal D, Kumar A (2023) Combinatorial enzyme therapy: a promising neoteric approach for bacterial biofilm disruption. Process Biochem 129:56\u201366. https:\/\/doi.org\/10.1016\/j.procbio.2023.02.022","journal-title":"Process Biochem"},{"key":"4817_CR178","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10020145","volume":"10","author":"A Vaitekenas","year":"2021","unstructured":"Vaitekenas A, Tai AS, Ramsay JP et al (2021) Pseudomonas aeruginosa resistance to bacteriophages and its prevention by strategic therapeutic cocktail formulation. Antibiotics 10:145. https:\/\/doi.org\/10.3390\/antibiotics10020145","journal-title":"Antibiotics"},{"key":"4817_CR179","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.synbio.2024.12.005","volume":"10","author":"S Varma","year":"2025","unstructured":"Varma S, Gulati KA, Sriramakrishnan J et al (2025) Environment signal dependent biocontainment systems for engineered organisms: leveraging triggered responses and combinatorial systems. Synth Syst Biotechnol 10:356\u2013364. https:\/\/doi.org\/10.1016\/j.synbio.2024.12.005","journal-title":"Synth Syst Biotechnol"},{"key":"4817_CR180","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00308","author":"A Vasala","year":"2020","unstructured":"Vasala A, Hyt\u00f6nen VP, Laitinen OH (2020) Modern tools for rapid diagnostics of antimicrobial resistance. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2020.00308","journal-title":"Front Cell Infect Microbiol"},{"key":"4817_CR181","doi-asserted-by":"publisher","first-page":"9308","DOI":"10.3390\/ijms21239308","volume":"21","author":"JC V\u00e1zquez-Ucha","year":"2020","unstructured":"V\u00e1zquez-Ucha JC, Arca-Su\u00e1rez J, Bou G, Beceiro A (2020) New carbapenemase inhibitors: clearing the way for the \u03b2-lactams. Int J Mol Sci 21:9308. https:\/\/doi.org\/10.3390\/ijms21239308","journal-title":"Int J Mol Sci"},{"key":"4817_CR182","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3390\/bioengineering12050469","volume":"12","author":"S Venkataraman","year":"2025","unstructured":"Venkataraman S, Shahgolzari M, Yavari A, Hefferon K (2025) Bacteriophages as targeted therapeutic vehicles: challenges and opportunities. Bioengineering 12:469. https:\/\/doi.org\/10.3390\/bioengineering12050469","journal-title":"Bioengineering"},{"key":"4817_CR183","doi-asserted-by":"publisher","unstructured":"Wang Y, Grainger DW (2022) Regulatory considerations specific to liposome drug development as complex drug products. Front Drug Deliv. https:\/\/doi.org\/10.3389\/fddev.2022.901281","DOI":"10.3389\/fddev.2022.901281"},{"key":"4817_CR184","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-023-00164-w","volume":"4","author":"X Wang","year":"2023","unstructured":"Wang X, Liu M, Yu C et al (2023) Biofilm formation: mechanistic insights and therapeutic targets. Mol Biomed 4:49. https:\/\/doi.org\/10.1186\/s43556-023-00164-w","journal-title":"Mol Biomed"},{"key":"4817_CR185","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/jac\/dkad060","volume":"78","author":"RR Watkins","year":"2023","unstructured":"Watkins RR, Thapaliya D, Lemonovich TL, Bonomo RA (2023) Gepotidacin: a novel, oral, \u2018first-in-class\u2019triazaacenaphthylene antibiotic for the treatment of uncomplicated urinary tract infections and urogenital gonorrhoea. J Antimicrob Chemother 78:1137\u20131142. https:\/\/doi.org\/10.1093\/jac\/dkad060","journal-title":"J Antimicrob Chemother"},{"key":"4817_CR186","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01132-8","volume":"19","author":"Y Wu","year":"2021","unstructured":"Wu Y, Battalapalli D, Hakeem MJ et al (2021) Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections. J Nanobiotechnology 19:401. https:\/\/doi.org\/10.1186\/s12951-021-01132-8","journal-title":"J Nanobiotechnology"},{"key":"4817_CR187","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1128\/IAI.02897-14","volume":"83","author":"Z Yang","year":"2015","unstructured":"Yang Z, Ramsey J, Hamza T et al (2015) Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies Actoxumab and Bezlotoxumab. Infect Immun 83:822\u2013831. https:\/\/doi.org\/10.1128\/IAI.02897-14","journal-title":"Infect Immun"},{"key":"4817_CR188","doi-asserted-by":"publisher","unstructured":"Yang S, Li X, Cang W, et al (2023) Biofilm tolerance, resistance and infections increasing threat of public health. Microbial Cell 10:233\u2013247. https:\/\/doi.org\/10.15698\/mic2023.11.807","DOI":"10.15698\/mic2023.11.807"},{"key":"4817_CR189","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-025-01605-1","volume":"25","author":"J Yang","year":"2025","unstructured":"Yang J, Li W, Hu Y et al (2025) Establishment of a rapid RAA-CRISPR\/Cas12a system targeting the recN gene for on-site detection of Streptococcus suis in livestock and fresh pork meat. Funct Integr Genomics 25:99. https:\/\/doi.org\/10.1007\/s10142-025-01605-1","journal-title":"Funct Integr Genomics"},{"key":"4817_CR190","doi-asserted-by":"publisher","first-page":"10020","DOI":"10.70322\/sbe.2025.10020","volume":"3","author":"Y Yuanming","year":"2025","unstructured":"Yuanming Y, Juntao S, Zhilong X (2025) CRISPR-armed phages: design, mechanisms, applications, and prospects in precision microbiome engineering. Syn Biol Eng 3:10020\u201310020. https:\/\/doi.org\/10.70322\/sbe.2025.10020","journal-title":"Syn Biol Eng"},{"issue":"1","key":"4817_CR191","first-page":"177","volume":"2","author":"I Zahir","year":"2025","unstructured":"Zahir I (2025) Aspergillomarasmine, a promising adjuvant to overcome antibiotic resistance. J Biol Biomed Res 2(1):177\u2013181","journal-title":"J Biol Biomed Res"},{"key":"4817_CR192","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1039\/D5LC00343A","volume":"25","author":"Y Zai","year":"2025","unstructured":"Zai Y, Min C, Wang Z et al (2025) Handheld RPA-based molecular POCT system for rapid, low-cost 8-plexed detection of respiratory pathogens at home. Lab Chip 25:2780\u20132794. https:\/\/doi.org\/10.1039\/D5LC00343A","journal-title":"Lab Chip"},{"key":"4817_CR193","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01120-23","author":"M Zalacain","year":"2024","unstructured":"Zalacain M, Achard P, Llanos A et al (2024) Meropenem-ANT3310, a unique \u03b2-lactam-\u03b2-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/aac.01120-23","journal-title":"Antimicrob Agents Chemother"},{"key":"4817_CR194","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40265-017-0851-9","volume":"78","author":"GG Zhanel","year":"2018","unstructured":"Zhanel GG, Lawrence CK, Adam H et al (2018) Imipenem-Relebactam and meropenem\u2013vaborbactam: two novel carbapenem-\u03b2-lactamase inhibitor combinations. Drugs 78:65\u201398. https:\/\/doi.org\/10.1007\/s40265-017-0851-9","journal-title":"Drugs"},{"key":"4817_CR195","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40265-019-1055-2","volume":"79","author":"GG Zhanel","year":"2019","unstructured":"Zhanel GG, Golden AR, Zelenitsky S et al (2019) Cefiderocol: a siderophore cephalosporin with activity against carbapenem-resistant and multidrug-resistant gram-negative bacilli. Drugs 79:271\u2013289. https:\/\/doi.org\/10.1007\/s40265-019-1055-2","journal-title":"Drugs"},{"key":"4817_CR196","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-025-03978-6","volume":"25","author":"X Zhang","year":"2025","unstructured":"Zhang X, Xiong D, Li X et al (2025) Lung-directed delivery of a ligand-mediated chimeric lysin has an enhanced ability to eradicate pulmonary and intracellular Staphylococcus aureus. BMC Microbiol 25:262. https:\/\/doi.org\/10.1186\/s12866-025-03978-6","journal-title":"BMC Microbiol"},{"key":"4817_CR197","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.3390\/ijms26115235","volume":"26","author":"X Zheng","year":"2025","unstructured":"Zheng X, Liu J, Wang X (2025) Quorum signaling molecules: interactions between plants and associated pathogens. Int J Mol Sci 26:5235. https:\/\/doi.org\/10.3390\/ijms26115235","journal-title":"Int J Mol Sci"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04817-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-04817-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04817-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:48:57Z","timestamp":1780120137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-04817-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":196,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4817"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-04817-6","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a review article. Neither experimental nor personal data included in this study; Hence no ethical approval or consent is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not contain any personal data. Hence, no consent is required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"276"}}